The Impact of Inflammation on Pathological Processes
DOI:
https://doi.org/10.59675/Keywords:
Acute Inflammation, pathological processes, Chronic InflammationAbstract
The term "inflammation" initially referred to a variety of well-known symptoms and signs, including erythema (redness), oedema, warmth, pain, and function loss (immobility and stiffness). Today, inflammation is understood to be a complicated, changing response to tissue damage brought on by noxious substances, certain environmental factors, trauma, infection or overuse. Some of these responses may be deleterious, as in many chronic disease states, while some could help with infection control and healing of wounds. Inflammation is a "second-line" defence against pathogenic microorganisms. The responses that inflammation causes are the basic processes of pathology. The suffix "-itis" denotes illnesses characterized by pathological inflammation. Cell-mediated and humoral immune system reactions largely produce inflammation. This study examines the association between inflammation and two major worldwide causes of death and morbidity: cardiovascular disease (CVD) and cancer.
References
Ansar W, Ghosh S, Ansar W, Ghosh S. Inflammation and inflammatory diseases, markers, and mediators: Role of CRP in some inflammatory diseases. In: Biology of C reactive protein in health and disease. 2016. p. 67-107.
Hawiger J, Zienkiewicz J. Decoding inflammation, its causes, genomic responses, and emerging countermeasures. Scand J Immunol. 2019;90(6):e12812.
Karunaweera N, Raju R, Gyengesi E, Münch G. Plant polyphenols as inhibitors of NF-κB induced cytokine production—a potential anti-inflammatory treatment for Alzheimer's disease?. Front Mol Neurosci. 2015;8:24.
Gudkov AV, Komarova EA. p53 and the carcinogenicity of chronic inflammation. Cold Spring Harb Perspect Med. 2016;6(11):a026161.
Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9(6):7204-18.
Rahimifard M, Maqbool F, Moeini-Nodeh S, Niaz K, Abdollahi M, Braidy N, et al. Targeting the TLR4 signaling pathway by polyphenols: a novel therapeutic strategy for neuroinflammation. Ageing Res Rev. 2017;36:11-19.
Ablasser A, Chen ZJ. cGAS in action: Expanding roles in immunity and inflammation. Science. 2019;363(6431):eaat8657.
Alharbi KS, Fuloria NK, Fuloria S, Rahman SB, Al-Malki WH, Shaikh MAJ, et al. Nuclear factor-kappa B and its role in inflammatory lung disease. Chem Biol Interact. 2021;345:109568.
Fitzgerald TL, Lertpiriyapong K, Cocco L, Martelli AM, Libra M, Candido S, et al. Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells. Adv Biol Regul. 2015;59:65-81.
Tegowski M, Baldwin A. Noncanonical NF-κB in cancer. Biomedicines. 2018;6(2):66.
Kim EK, Choi EJ. Compromised MAPK signaling in human diseases: an update. Arch Toxicol. 2015;89:867-82.
Hotamisligil GS, Davis RJ. Cell signaling and stress responses. Cold Spring Harb Perspect Biol. 2016;8(10):a006072.
Park HB, Baek KH. E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers. Biochim Biophys Acta Rev Cancer. 2022;1877(3):188736.
Mullen M, Gonzalez-Perez RR. Leptin-induced JAK/STAT signaling and cancer growth. Vaccines (Basel). 2016;4(3):26.
Morris R, Kershaw NJ, Babon JJ. The molecular details of cytokine signaling via the JAK/STAT pathway. Protein Sci. 2018;27(12):1984-2009.
Jain M, Singh MK, Shyam H, Mishra A, Kumar S, Kumar A, et al. Role of JAK/STAT in the neuroinflammation and its association with neurological disorders. Ann Neurosci. 2021;28(3-4):191-200.
Chan DS, Bandera EV, Greenwood DC, Norat T. Circulating C-reactive protein and breast cancer risk—systematic literature review and meta-analysis of prospective cohort studies. Cancer Epidemiol Biomarkers Prev. 2015;24(10):1439-49.
Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.
Avan A, Tavakoly Sany SB, Ghayour-Mobarhan M, Rahimi HR, Tajfard M, Ferns G. Serum C-reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice. J Cell Physiol. 2018;233(11):8508-25.
Mantovani A. The inflammation–cancer connection. FEBS J. 2018;285(4):638-40.
Hoppe C, Jacob E, Styles L, Kuypers F, Larkin S, Vichinsky E. Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial. Br J Haematol. 2017;177(4):620-9.
Bruno AS, Lopes PD, de Oliveira K, de Oliveira AK, de Assis Cau SB. Vascular inflammation in hypertension: targeting lipid mediators unbalance and nitrosative stress. Curr Hypertens Rev. 2021;17(1):35-46.
Teixeira-Gomes A, Laffon B, Valdiglesias V, Gostner JM, Felder T, Costa C, et al. Exploring early detection of frailty syndrome in older adults: evaluation of oxi-immune markers, clinical parameters and modifiable risk factors. Antioxidants (Basel). 2021;10(12):1975.
Nagabhushana D, Mahesh KP. Chronic inflammation in oral cancer—adding fuel to fire. Turk J Physiother Rehabil. 2021;32(3):3.
Chavez-Dominguez R, Perez-Medina M, Aguilar-Cazares D, Galicia-Velasco M, Meneses-Flores M, Islas-Vazquez L, et al. Old and new players of inflammation and their relationship with cancer development. Front Oncol. 2021;11:722999.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Academic International Journal of Medical Sciences
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
